New injection could beat tough eye infections that drops Can't handle

NCT ID NCT07394257

Recruiting now Disease control Sponsor: Minia University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether injecting the antibiotic moxifloxacin directly into the cornea can help treat bacterial eye infections that don't improve with standard antibiotic drops. About 60 adults with stubborn corneal infections will receive either the injection plus drops or drops alone. The goal is to see if the injection speeds up healing and improves vision.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: moxifloxacin
What this could lead to: If it works, this could offer a better way to treat deep corneal infections that don't heal with standard antibiotic eye drops, potentially saving eyesight.
What could go wrong: This is a small, early-stage trial with only 60 participants, so results may not apply to everyone. The injection itself carries risks like corneal damage or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BACTERIAL KERATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

corneal infection corneal ulcer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BACTERIAL KERATITIS CORNEAL ULCER RECALCITRANT INFECTIOUS KERATITIS

Contacts and locations

Locations

Mahmoud Ramadan Amer
RECRUITING

Minya, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.